Share on Pinterest A new trial finds that GLP-1 agonists may help reduce knee osteoarthritis-related pain. Westend61/Getty ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

"Obesity-related knee osteoarthritis is a progressive condition that can lead to pain and stiffness of the knee and impair ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

OA often comes on gradually, and its symptoms can ebb and flow over time. While it is wise to speak to a healthcare provider about any symptoms you experience, there are several steps you can take at ...

1, 2024 (HealthDay News) -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide -- the ...